OIS@ASCRS 2013 Executive Summary – Eye on Innovation

OIS@ASCRS 2013 Executive Summary – Eye on Innovation
The Second Annual OIS@ASCRS – Ophthalmology Innovation Summit at the American Society of Cataract and Refractive Surgery was held in San Francisco on April 18, 2013. The conference attracted 325 attendees from 29 US states and 21 countries.

The purpose of OIS is to create an ecosystem of clinical, technology and business. Uniting this diverse group of key players in the ophthalmic field fosters innovation and facilitates business transactions. The conference provides a forum for addressing key issues impacting the ophthalmic field and a platform to showcase the most promising private ophthalmic companies. During this year’s Summit, William J. Link, PhD, OIS Co-Chair and Managing Director, Versant Ventures, said, “OIS is resonating because in the same room we’re bringing together the inventors, the early adopting clinicians, the sources of capital and industry—those four constituencies that are required to power innovation.”

Key topics at the Summit included the funding of ophthalmic innovation, process improvements at the US Food and Drug Administration (FDA), as well as the emerging fields of refractive cataract surgery, presbyopia correction, and micro-invasive glaucoma surgery (MIGS).

View the full executive summary below:

SHARE THIS ARTICLE WITH YOUR COLLEAGUES:

RECOMMENDED FOR YOU

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

Eyenuk’s EyeArt AI System Showing Its Value

Eyenuk’s EyeArt AI System Showing Its Value

New J&J Vision CMO Steps onto a Very Large Stage

New J&J Vision CMO Steps onto a Very Large Stage

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

Aldeyra Eyes Lucrative DED, Conjunctivitis Markets

Aldeyra Eyes Lucrative DED, Conjunctivitis Markets

About The Author

Tom Salemi

Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products. At Healthegy, Tom hosts the OIS Podcast and MedtechTalk, contributes to the Engage and Eye on Innovation newsletters and assists in the agenda development of new and existing conferences.

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Opthalmologic Innovation To Your Inbox.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

SUBSCRIBE TO OIS WEEKLY

Get our monthly newsletter about the latest in opthalmologic innovation.

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

STAY CONNECTED

NEW VIDEOS

PODCASTS